Wealthfront Advisers’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Buy |
10,260
+2,515
| +32% | +$318K | ﹤0.01% | 639 |
|
|
2025
Q1 | $991K | Sell |
7,745
-3,921
| -34% | -$501K | ﹤0.01% | 660 |
|
|
2024
Q4 | $1.54M | Buy |
11,666
+1,933
| +20% | +$256K | ﹤0.01% | 580 |
|
|
2024
Q3 | $1.42M | Buy |
9,733
+260
| +3% | +$37.9K | ﹤0.01% | 579 |
|
|
2024
Q2 | $1.3M | Sell |
9,473
-1,236
| -12% | -$170K | ﹤0.01% | 573 |
|
|
2024
Q1 | $1.47M | Buy |
10,709
+1,933
| +22% | +$265K | 0.01% | 541 |
|
|
2023
Q4 | $1.19M | Buy |
8,776
+3,611
| +70% | +$491K | ﹤0.01% | 565 |
|
|
2023
Q3 | $632K | Sell |
5,165
-1,816
| -26% | -$222K | ﹤0.01% | 648 |
|
|
2023
Q2 | $886K | Buy |
6,981
+1,241
| +22% | +$158K | ﹤0.01% | 579 |
|
|
2023
Q1 | $741K | Buy |
5,740
+532
| +10% | +$68.7K | ﹤0.01% | 581 |
|
|
2022
Q4 | $684K | Buy |
5,208
+370
| +8% | +$48.6K | ﹤0.01% | 576 |
|
|
2022
Q3 | $566K | Buy |
4,838
+630
| +15% | +$73.7K | ﹤0.01% | 571 |
|
|
2022
Q2 | $495K | Buy |
4,208
+162
| +4% | +$19.1K | ﹤0.01% | 591 |
|
|
2022
Q1 | $527K | Buy |
4,046
+945
| +30% | +$123K | ﹤0.01% | 621 |
|
|
2021
Q4 | $473K | Buy |
+3,101
| New | +$473K | ﹤0.01% | 605 |
|